STERIS plc STE
252.30 USD -1.82 (-0.72%)
At closeNov 6, 2026, 4:08 PM EST
252.30 0.00 0.00%
After hours · Nov 6, 4:08 PM ET
248.81 Day range 253.44
195.14 52-week range 269.44
- YTD
- -0.48%
- 1 year
- -2.98%
News
benzinga.com Keybanc Maintains Overweight on Steris, Raises Price Target to $284 Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and raises the price target from $269 to $284.
zacks.com STE Stock Up on Q2 Earnings & Revenue Beat, '27 EPS View Up STERIS beats Q2 fiscal 2027 earnings and revenue estimates, fueled by strong segment growth and margin gains, and raises its full-year adjusted EPS outlook.
benzinga.com Steris Q2 2027 Earnings Call Transcript Steris (NYSE:STE) reported second-quarter financial results on Thursday. The transcript from the company’s second-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Compared to Estimates, Steris (STE) Q2 Earnings: A Look at Key Metrics Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
zacks.com Steris (STE) Q2 Earnings and Revenues Surpass Estimates Steris (STE) came out with quarterly earnings of $2.94 per share, beating the Zacks Consensus Estimate of $2.67 per share. This compares to earnings of $2.47 per share a year ago.
benzinga.com Steris Raises FY2027 Adj EPS Guidance from $11.00-$11.30 to $11.35-$11.55 vs $11.18 Est; Lowers FY2027 Sales Guidance of $6.352B-$6.411B vs $6.373B Est Steris (NYSE:STE) raises FY2027 Adj EPS guidance from $11.00-$11.30 to $11.35-$11.55 vs $11.18 analyst estimate. Lowers FY2027 sales outlook from $6.352 billion-$6.411 billion to $6.352…
benzinga.com Steris Q2 Adj. EPS $2.94 Beats $2.68 Estimate, Sales $1.589B Beat $1.562B Estimate Steris (NYSE:STE) reported quarterly earnings of $2.94 per share which beat the analyst consensus estimate of $2.68 by 9.7 percent. This is a 19.03 percent increase over earnings of $2.47 per share…
globenewswire.com STERIS Announces Financial Results for Fiscal 2027 Second Quarter DUBLIN, IRELAND, Nov. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 second quarter ended September 30, 2026.…
zacks.com STERIS Set to Report Q2 Earnings: What's in the Cards for the Stock? STE's second-quarter fiscal 2027 earnings may benefit from Healthcare growth, recent acquisitions, easing AST comparisons and continued margin expansion.
benzinga.com STERIS Inks Deal To Acquire Xodus Medical For $2.1B STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced that STERIS Corporation, a wholly owned subsidiary of the Company, has signed a definitive agreement to acquire Xodus Medical, Inc.,…
benzinga.com Full Transcript: Steris Q1 2027 Earnings Call Steris (NYSE:STE) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial…
benzinga.com Top 3 Health Care Stocks That May Rocket Higher In September CVS, Steris and Baxter are oversold healthcare stocks with RSI readings near or below 30, potentially offering undervalued buying opportunities.
benzinga.com Recent Report Shows That Rep. Jared Moskowitz Sold Up to $30K Worth of Steris Stock An official report on August 27, 2026 reveals Representative Jared Moskowitz's recent sale of Steris (NYSE:STE) stock, valued between $2,002 and $30,000. The transaction took place on July 13, 2026,…- benzinga.com Piper Sandler Reiterates Overweight on Steris, Raises Price Target to $275 Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Overweight and raises the price target from $270 to $275.
benzinga.com Steris Widens FY2027 Adj EPS Guidance from $11.10-$11.30 to $11.00-$11.30 vs $11.16 Est; Affirms FY2027 Sales Guidance of $6.352B-$6.411B vs $6.371B Est Steris (NYSE:STE) widens FY2027 Adj EPS guidance from $11.10-$11.30 to $11.00-$11.30 vs $11.16 analyst estimate. Affirms FY2027 sales outlook from $6.352 billion-$6.411 billion to $6.352…- benzinga.com STERIS Plans $600M Investment To Construct Formulated Chemistries Manufacturing And Distribution Center Of Excellence In North Carolina STERIS plc (NYSE:STE) ("STERIS" or the "Company") today announced that it will be investing $600 million to build a formulated chemistries manufacturing and distribution Center of Excellence in North
benzinga.com STERIS Raises Quarterly Dividend From $0.63 To $0.69 Per Share STERIS plc (NYSE:STE) ("STERIS" or the "Company") announced today that the Company will distribute a quarterly interim dividend of $0.69 per share. This represents a $0.06 increase in the dividend and- benzinga.com UBS Initiates Coverage On Steris with Buy Rating, Announces Price Target of $275 UBS analyst Patrick Wood initiates coverage on Steris (NYSE:STE) with a Buy rating and announces Price Target of $275.
- benzinga.com Keybanc Maintains Overweight on Steris, Lowers Price Target to $269 Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and lowers the price target from $291 to $269.
benzinga.com Transcript: Steris Q4 2026 Earnings Conference Call - benzinga.com Steris Sees FY2027 Adj EPS $11.10-$11.30 vs $11.10 Est; Sees Sales $6.352B-$6.411B vs $6.316B Est Steris (NYSE:STE) is looking for FY2027 Adj EPS of $11.10-$11.30 vs $11.10 analyst estimate. sees sales of $6.352 billion-$6.411 billion vs $6.316 billion analyst estimate.
- benzinga.com Steris Q4 Adj. EPS $2.83 Misses $2.85 Estimate, Sales $1.588B Miss $1.595B Estimate Steris (NYSE:STE) reported quarterly earnings of $2.83 per share which missed the analyst consensus estimate of $2.85 by 0.7 percent. This is a 3.28 percent increase over earnings of $2.74 per share…
benzinga.com Earnings Scheduled For May 11, 2026 
benzinga.com April McClain Delaney Bought Up To 15K Worth of Entegris Stock: Here's What You Should Know Rep. April McClain Delaney disclosed purchases of Entegris stock and several industrial and healthcare stocks in April, adding semiconductor exposure as AI-driven demand continues to support…
benzinga.com Earnings Breakdown: Steris Q3 - benzinga.com Steris Q3 Adj. EPS $2.53, Inline, Sales $1.500B Beat $1.481B Estimate Steris (NYSE:STE) reported quarterly earnings of $2.53 per share which met the analyst consensus estimate. This is a 9.05 percent increase over earnings of $2.32 per share from the same period last…
- benzinga.com Earnings Scheduled For February 4, 2026
benzinga.com Sotera Health Trades At Deep Discount Despite Best-In-Class Margins: Analyst Sotera Health, a sterilization solutions provider, is gaining investor attention due to easing litigation and improving cash flow.
benzinga.com Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
benzinga.com Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be…
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday - benzinga.com Earnings Scheduled For August 6, 2025
benzinga.com Deere Posts Upbeat Earnings, Joins Foot Locker, Boot Barn, Cisco And Other Big Stocks Moving Higher On Thursday - benzinga.com Earnings Scheduled For May 14, 2025
benzinga.com Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and Arista Networks.
benzinga.com Earnings Scheduled For February 5, 2025 
benzinga.com Earnings Scheduled For February 7, 2024 Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
benzinga.com Earnings Scheduled For November 7, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.- benzinga.com Earnings Scheduled For August 1, 2023 Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for its first quarter. • BP (NYSE:BP) is projected to report quarterly earnings at $1.21 per share on…
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
- benzinga.com Earnings Scheduled For May 10, 2023 Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
- benzinga.com Earnings Scheduled For February 8, 2023 Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is likely to report earnings for its fourth quarter. • Bunge (NYSE:BG) is projected to report quarterly earnings at $3.22 per share on…
- benzinga.com Earnings Scheduled For November 9, 2022 Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.- benzinga.com Earnings Scheduled For August 2, 2022 Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
- benzinga.com Earnings Scheduled For May 11, 2022 Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
- benzinga.com Stocks That Hit 52-Week Highs On Thursday On Thursday, 75 stocks made new 52-week highs.
- benzinga.com Earnings Scheduled For February 8, 2022 Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.